Breadcrumb

  1. Our scientific focus
  2. Research and development
  3. Research domains

Research domains

A frontrunner in cutting edge ophthalmology therapy

We are focused on corneal disorders that lack effective treatment options and on glaucoma and retinal disorders that are increasing in prevalence due to the aging of society. Our proprietary drug discovery programme is also targeting the development of antibiotic compounds as well as other systemic ophthalmology treatments.

We are also expanding our genomic drug discovery, a field at the forefront of modern life science. Through information exchange and joint study efforts with renowned genomic drug discovery external research institutes, we are committed to discovering new breakthroughs in the treatment of eye disorders.

Primary R&D domains

Domain Disorder
Corneal and conjunctival disorders/allergies Corneal and conjunctival epithelial disorders 
Persistent corneal epithelial defects
Vernal keratoconjunctivitis
Dry eye disease
Bacterial conjunctivitis
Allergic conjunctivitis
Glaucoma and ocular hypertension Glaucoma/ocular hypertension
Retinal/uveal disorders Diabetic macular oedema
Uveitis